CTOs on the Move

10X Genomics

www.10xgenomics.com

 
10x Genomics meets the critical need for long range, structural and cellular information, with an innovative system that transforms short-read sequencing technologies. Our Chromium™ System supports comprehensive genomics and high-throughput single cell transcriptomics. It enables researchers to discover previously inaccessible genomic information at unprecedented scale, including phased structural variants, phased single nucleotide variants, and dynamic gene expression of individual cells—while leveraging their existing sequencing systems and workflows.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.10xgenomics.com
  • 7068 Koll Center Parkway Suite 401
    Pleasanton, CA USA 94566
  • Phone: 925.401.7300

Executives

Name Title Contact Details
Jason Gao
Head of Information Security Profile

Funding

10X Genomics raised $55M on 03/17/2016
10X Genomics raised $75M on 04/26/2018
10X Genomics raised $50M on 04/26/2018
10X Genomics raised $35M on 01/07/2019

Similar Companies

Integrated Genomics Inc

Integrated Genomics Inc is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nuvelo

Nuvelo, Inc. is a San Carlos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Assurex Health

Assurex Health is a personalized medicine company that specializes in helping physicians determine the right medication for individual patients who have Behavioral Health disorders. The GeneSight analysis is based on pharmacogenomics, the study of the genetic factors that influence an individual`s response to drug treatments.

Icagen

Icagen is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wheeler Bio

A disruptive new biopharmaceutical CDMO, we are pushing the boundaries of biomanufacturing and solving an outdated industry bottleneck with a unique partnering model. By bringing together biologics drug innovators, discovery CROs, and CDMOs, we are accelerating the translation of therapeutic innovation to clinical impact.